BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37191144)

  • 1. Deletion of Androgen Receptors From Kisspeptin Neurons Prevents PCOS Features in a Letrozole Mouse Model.
    Decourt C; Watanabe Y; Evans MC; Inglis MA; Fisher LC; Jasoni CL; Campbell RE; Anderson GM
    Endocrinology; 2023 Apr; 164(6):. PubMed ID: 37191144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of electroacupuncture on the kisspeptin-gonadotropin-releasing hormone (GnRH) /luteinizing hormone (LH) neural circuit abnormalities and androgen receptor expression of kisspeptin/neurokinin B/dynorphin neurons in PCOS rats.
    Xu G; Zhao X; Li Z; Hu J; Li X; Li J; Chen Y
    J Ovarian Res; 2023 Jan; 16(1):15. PubMed ID: 36650561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperactive LH Pulses and Elevated Kisspeptin and NKB Gene Expression in the Arcuate Nucleus of a PCOS Mouse Model.
    Esparza LA; Schafer D; Ho BS; Thackray VG; Kauffman AS
    Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32031594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating GABA Neuron-Specific Androgen Receptor Knockout in two Hyperandrogenic Models of PCOS.
    Sucquart IE; Coyle C; Rodriguez Paris V; Prescott M; Glendining KA; Potapov K; Begg DP; Gilchrist RB; Walters KA; Campbell RE
    Endocrinology; 2024 May; 165(7):. PubMed ID: 38788194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.
    Kauffman AS; Thackray VG; Ryan GE; Tolson KP; Glidewell-Kenney CA; Semaan SJ; Poling MC; Iwata N; Breen KM; Duleba AJ; Stener-Victorin E; Shimasaki S; Webster NJ; Mellon PL
    Biol Reprod; 2015 Sep; 93(3):69. PubMed ID: 26203175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization.
    Caldwell AS; Eid S; Kay CR; Jimenez M; McMahon AC; Desai R; Allan CM; Smith JT; Handelsman DJ; Walters KA
    Endocrinology; 2015 Apr; 156(4):1441-52. PubMed ID: 25643156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS.
    Ryan GE; Malik S; Mellon PL
    Endocrinology; 2018 Apr; 159(4):1734-1747. PubMed ID: 29471436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome.
    Arroyo P; Ho BS; Sau L; Kelley ST; Thackray VG
    PLoS One; 2019; 14(9):e0223274. PubMed ID: 31568518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive Deficits Induced by Prenatal Antimüllerian Hormone Exposure Require Androgen Receptor in Kisspeptin Cells.
    Ho EV; Shi C; Cassin J; He MY; Nguyen RD; Ryan GE; Tonsfeldt KJ; Mellon PL
    Endocrinology; 2021 Dec; 162(12):. PubMed ID: 34529765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model.
    Xiong T; Rodriguez Paris V; Edwards MC; Hu Y; Cochran BJ; Rye KA; Ledger WL; Padmanabhan V; Handelsman DJ; Gilchrist RB; Walters KA
    Am J Physiol Endocrinol Metab; 2022 Aug; 323(2):E145-E158. PubMed ID: 35658542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kisspeptin expression features in the arcuate and anteroventral periventricular nuclei of hypothalamus of letrozole-induced polycystic ovarian syndrome in rats.
    Aliabadi E; Namavar MR; Mortezaee K; Toolee H; Keshtgar S; Mirkhani H; Akbari M; Rastegar T; Solhjoo S
    Arch Gynecol Obstet; 2017 Nov; 296(5):957-963. PubMed ID: 28875319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurokinin 3 Receptor Antagonism Ameliorates Key Metabolic Features in a Hyperandrogenic PCOS Mouse Model.
    Sucquart IE; Nagarkar R; Edwards MC; Rodriguez Paris V; Aflatounian A; Bertoldo MJ; Campbell RE; Gilchrist RB; Begg DP; Handelsman DJ; Padmanabhan V; Anderson RA; Walters KA
    Endocrinology; 2021 May; 162(5):. PubMed ID: 33522579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apelin receptor modulation mitigates letrozole-induced polycystic ovarian pathogenesis in mice.
    Anima B; Gurusubramanian G; Roy VK
    Cytokine; 2024 Jul; 179():156639. PubMed ID: 38733946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model.
    Aflatounian A; Edwards MC; Rodriguez Paris V; Bertoldo MJ; Desai R; Gilchrist RB; Ledger WL; Handelsman DJ; Walters KA
    J Endocrinol; 2020 Jun; 245(3):381-395. PubMed ID: 32229702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal androgen treatment impairs the suprachiasmatic nucleus arginine-vasopressin to kisspeptin neuron circuit in female mice.
    Jamieson BB; Moore AM; Lohr DB; Thomas SX; Coolen LM; Lehman MN; Campbell RE; Piet R
    Front Endocrinol (Lausanne); 2022; 13():951344. PubMed ID: 35992143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.
    Romero-Ruiz A; Skorupskaite K; Gaytan F; Torres E; Perdices-Lopez C; Mannaerts BM; Qi S; Leon S; Manfredi-Lozano M; Lopez-Rodriguez C; Avendaño MS; Sanchez-Garrido MA; Vazquez MJ; Pinilla L; van Duin M; Kohout TA; Anderson RA; Tena-Sempere M
    Hum Reprod; 2019 Dec; 34(12):2495-2512. PubMed ID: 31820802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of kisspeptin in androgen-induced hypothalamic endoplasmic reticulum stress and its rescuing effect in PCOS rats.
    Yuan C; Huang WQ; Guo JH; Liu XY; Yang JZ; Chen JJ; Wu Y; Ruan YC; Liu JY; Cui YG; Diao FY; Chan HC
    Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166242. PubMed ID: 34389474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome.
    Caldwell ASL; Edwards MC; Desai R; Jimenez M; Gilchrist RB; Handelsman DJ; Walters KA
    Proc Natl Acad Sci U S A; 2017 Apr; 114(16):E3334-E3343. PubMed ID: 28320971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crocetin attenuates DHT-induced polycystic ovary syndrome in mice via revising kisspeptin neurons.
    Hu Q; Jin J; Zhou H; Yu D; Qian W; Zhong Y; Zhang J; Tang C; Liu P; Zhou Y; Wang X; Sheng L
    Biomed Pharmacother; 2018 Nov; 107():1363-1369. PubMed ID: 30257351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.